Sanofi becomes the first pharmaceutical company to achieve WELL Gold standard in Vietnam

Vinh Phú |

On February 12, Sanofi-Aventis Vietnam Co., Ltd. (Sanofi Vietnam) marked an important milestone when it became the first pharmaceutical company in Vietnam to have an office that achieved WELL Gold Certification, recognized by the International WELL Building Institute (IWBITM). Sanofi Vietnam was also honored to receive the Silver Award in the category For a Better Future - Sustainable Environmental Development in the ASIAN Design Awards 2024, organized by Better Future Awards.

In June 2024, Sanofi Vietnam opened two offices in Ho Chi Minh City with a working space designed according to WELL standards. In the first quarter of 2025, this office officially became the first office among pharmaceutical companies in Vietnam to achieve WELL Gold Certification.

Sanofi also creates optimal conditions for professional development and takes care of the physical and mental health of employees.

Mr. Burak Pekmezci, General Director of Sanofi-Aventis Vietnam, said: “The two international certifications are a testament to Sanofi’s commitment to building a creative and sustainable working environment, focusing on improving the overall health and happiness of employees.”

With the WELL Gold Certification and the Better Future - Environmental Sustainability Silver Award, Sanofi Vietnam not only affirms its pioneering position in the pharmaceutical industry with a healthy and happy working environment but also creates a breakthrough in attracting talent and enhancing its reputation in the Vietnamese market. This is an important step forward for Sanofi to realize its vision of becoming a global leader in the field of immunology.

Vinh Phú
TIN LIÊN QUAN

Sanofi updates information on distribution of Alphachymotrypsine Choay® product

|

Following Lotus’ announcement of the acquisition of Alphachymotrypsine Choay® in Vietnam and Cambodia from Sanofi, the two companies have issued a follow-up announcement, providing updates on new distribution arrangements for the product to ensure continued supply to patients.

Sanofi organizes a series of seminars on the importance of seasonal flu vaccination

|

Sanofi Pharmaceutical Group organized a series of seminars on Seasonal Flu, gathering more than 400 regional and global medical experts to attend. This series of scientific seminars is one of the efforts to demonstrate Sanofi Group's commitment to continuously updating the latest scientific knowledge to the medical professional community. Seasonal flu is not a common cold, but can cause dangerous complications, especially for the elderly and people with chronic underlying diseases.

Sanofi updates information on distribution of Alphachymotrypsine Choay® product

Vinh Phú |

Following Lotus’ announcement of the acquisition of Alphachymotrypsine Choay® in Vietnam and Cambodia from Sanofi, the two companies have issued a follow-up announcement, providing updates on new distribution arrangements for the product to ensure continued supply to patients.

Sanofi organizes a series of seminars on the importance of seasonal flu vaccination

Vinh Phú |

Sanofi Pharmaceutical Group organized a series of seminars on Seasonal Flu, gathering more than 400 regional and global medical experts to attend. This series of scientific seminars is one of the efforts to demonstrate Sanofi Group's commitment to continuously updating the latest scientific knowledge to the medical professional community. Seasonal flu is not a common cold, but can cause dangerous complications, especially for the elderly and people with chronic underlying diseases.

Sanofi Việt Nam triển khai dự án Mở rộng mảng xanh cho TPHCM

Vinh Phú |

Ngày 5.6, nhằm hưởng ứng Ngày Môi trường Thế giới và tháng hành động vì môi trường, Công ty TNHH Sanofi-Aventis Việt Nam (Sanofi Việt Nam) hợp tác cùng Trung tâm Bảo tồn Thiên nhiên Gaia (Gaia) triển khai dự án "Mở rộng mảng xanh cho Thành phố Hồ Chí Minh" giai đoạn 2024 – 2026 với mục tiêu trồng 100 cây xanh tại các trường học trên địa bàn thành phố.